Unichem Laboratories has received ANDA approval for its Aripiprazole Tablets USP, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg
from the United States Food and Drug Administration (USFDA) to market a generic version of AbilifyTablets, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg, of Otsuka Pharmaceutical Company.
Aripiraprazole tablets are indicated for Schizophrenia and Irritability associated with Autistic Disorder. The product will be commercialized from Unichem's Ghaziabad Plant.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
